-
Contains 15 relevant, practice-oriented topics including T cell tolerance/Treg defects; gene defects in early onset IBD/colitis; autoimmunity with cytoskeletal d/o - WAS, DOCK8; autoimmune and autoinflammatory neurologic conditions; genes in HLH and that predispose to MAS; mutations in severe COVID/MISC; and more.
-
Provides in-depth clinical reviews on new and emerging rheumatic diseases, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Approach to Diagnosing Inborn Errors of ImmunityType I Interferonopathies: A Clinical Review
Suppressor of Cytokine Signaling 1 Haploinsufficiency: A New Driver of Autoimmunity and Immunodysregulation
Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment
COPA Syndrome from Diagnosis to Treatment: A Clinician's Guide
NF-kB and Related Autoimmune and Autoinflammatory Diseases
Expanding IPEX: Inborn Errors of Regulatory T Cells
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders
Genetic Defects in Early-Onset Inflammatory Bowel Disease
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis
Targeted Treatment of Diseases of Immune Dysregulation
Authors
Erin Janssen Department of Pediatrics, Harvard Medical School, Boston MA, USAClinical Fellow in Rheumatology, Division of Immunology, Department of Medicine, Children's Hospital Boston, Boston MA, USA.